Home
About
Overview
Sharing Data
ORCID
Help
History (1)
C3a receptor antagonism as a novel therapeutic target for chronic rhinosinusitis.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
C3a receptor antagonism as a novel therapeutic target for chronic rhinosinusitis.
C3a receptor antagonism as a novel therapeutic target for chronic rhinosinusitis. Mucosal Immunol. 2018 09; 11(5):1375-1385.
View in:
PubMed
subject areas
Animals
Aspergillus fumigatus
Cell Line
Chronic Disease
Complement C3
Disease Models, Animal
Epithelial Cells
Humans
Inflammation
Mice
Mice, Inbred BALB C
Nasal Mucosa
Nasal Polyps
Proteome
Receptors, Complement
Rhinosporidiosis
Signal Transduction
authors with profiles
Jennifer L Mulligan
Rodney J. Schlosser
Carl Atkinson
Stephen Tomlinson
Sarah Elizabeth Stephenson
Richard R. Drake